FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising the femA gene

• US 5,587,307 A
• Filed: 10/27/1994
• Issued: 12/24/1996
• Est. Priority Date: 04/30/1993
• Status: Expired due to Fees

• Current Assignee: Eli Lilly and Company
• Original Assignee: Eli Lilly and Company
• Inventors: Alborn, William E. Jr., Unal, Serhat, Hoskins, JoAnn, Skatrud, Paul L.
• Primary Examiner(s): Hendricks, Keith D.
• Application Number:
  US08/330,154
• Time in Patent Office: 789 Days
• Field of Search: 530/350, 435/69.1, 435/320.1, 435/252.3, 435/240.1, 435/240.2, 435/240.4, 435/252.31, 435/252.32, 435/252.33, 435/252.34, 435/252.35, 536/23.7
• US Class Current: 435/325
• CPC Class Codes: C07K 14/31 from Staphylococcus (G)

Abstract

The instant invention provides the femA gene of Staphylococcus epidermidis and all degenerate sequences thereof, the protein encoded by the femA gene (FemA), and vectors and microorganisms comprising genes encoding the FemA protein.

Claims

1. A DNA compound that comprises an isolated DNA sequence which is SEQ ID NO:

1.

2. A recombinant DNA vector that comprises an isolated DNA sequence of SEQ ID NO:

1.

3. A recombinant DNA vector of claim 2 that further comprises a promoter positioned to drive expression of said isolated DNA sequence.

5. A recombinant host cell transformed with a recombinant DNA vector of claim 2.

4. A method for expressing SEQ ID NO:

2 in a recombinant host cell;

said method comprising culturing a recombinant host cell transformed with a recombinant DNA vector that comprises an isolated DNA sequence of SEQ ID NO;

1.